A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment

Clinical trial NCT04933695 · TERMINATED

Trial details

NCT number: NCT04933695
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2022-01-28
Primary completion: 2025-05-28
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.